Legal Representation
Attorney
Constantine Linnik
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 1, 2020 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Dec 1, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Aug 31, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 24, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 24, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 24, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 21, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 21, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 21, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 16, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 4, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 15, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 9, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Transdermal patches featuring CBD, or hemp-derived CBD, and other ingredients, for arthritic pain, muscle pain, anxiety and/or other neurological, inflammatory, or other conditions; all of the foregoing not including any goods which are noncompliant with the Federal Controlled Substances Act
First Use Anywhere:
Feb 1, 2019
First Use in Commerce:
Feb 1, 2019
Class 010
Drug delivery patches sold without medication
First Use Anywhere:
Feb 1, 2019
First Use in Commerce:
Feb 1, 2019
Classification
International Classes
005
010